Comparison of two screws for maxillary expansion in prepubertal children
ISRCTN | ISRCTN18263886 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN18263886 |
Secondary identifying numbers | LF1 |
- Submission date
- 04/10/2016
- Registration date
- 08/11/2016
- Last edited
- 04/01/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
The dental arches are the two arches of teeth, one on each jaw (upper and lower arch). A posterior crossbite is a misalignment of the teeth that occurs when the upper arch and/or the upper jaw are narrower than the lower arch, and can happen on one (unilateral) or both (bilateral) sides of the mouth. Treatment of a posterior crossbite usually involves expanding the upper arch with either a fixed or removable orthodontic appliance (brace). Expansion with fixed expanders may be more successful than removable expansion plates at correcting posterior crossbites in children. Growing patients may report undesirable side effects during the expansion phase with fixed expanders, such as pain and mouth ulcers. Pain could be reduced by modifying the amount of force applied during the expansion. It is not known whether an expansion screw that uses moderate and continuous force could cause less pain compared with a standard screw that uses heavy and intermittent force. The aim of this study is to compare the effectiveness and side effects of a screw for maxillary expansion that uses moderate and continuous force with a standard expansion screw that uses heavy and intermittent force.
Who can participate?
Children aged between 6 and 14 with a posterior crossbite
What does the study involve?
Participants are randomly allocated to be treated with one of two types of rapid maxillary expanders, either with an expansion screw that uses moderate and continuous force or a standard expansion screw that uses heavy and intermittent force. Participants are followed-up every 2 weeks during the active phase of expansion (about 3 months) and then they are checked every month until the completion of the study (1 year after the start of treatment).
What are the possible benefits and risks of participating?
Participants may benefit from correction of their posterior crossbite. The possible risks include pain and mouth ulcers.
Where is the study run from?
1. University of Florence (Italy)
2. University of Rome Tor Vergata (Italy)
When is the study starting and how long is it expected to run for?
January 2016 to September 2018
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Dr Lorenzo Franchi
lorenzo.franchi@unifi.it
Contact information
Public
Via del Ponte di Mezzo 46-48
Florence
50127
Italy
0000-0002-2072-460X | |
Phone | +39 (0)55 7945602 |
lorenzo.franchi@unifi.it |
Study information
Study design | Three-centered superior parallel two-group randomized clinical trial with balanced randomization and blind examiner |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | Comparison of two screws for maxillary expansion in prepubertal children: a multicenter randomized controlled trial |
Study objectives | The objective of this randomized controlled trial (RCT) is to compare the efficacy and side effects of a screw for maxillary expansion that uses moderate and continuous forces (test) and a standard expansion screw that uses heavy and intermittent forces (control). |
Ethics approval(s) | Pediatric Ethics Committee of the Meyer Paediatric Hospital, 29/04/2016, ref: 57/2016 |
Health condition(s) or problem(s) studied | Maxillary arch constriction |
Intervention | Patients will be randomized to receive a screw for maxillary expansion that uses moderate and continuous forces (Memoria Leaf Spring Activated Expander A2704, Leone SpA) (test) or a standard expansion screw that uses heavy and intermittent forces (Rapid Expander with Telescopic Guides A2620, Leone SpA) (control). Randomisation: Computer-generated, balanced, with allocation concealment by opaque sequentially numbered sealed envelopes. The test expander will be activated by the operators every 2 weeks. The control expander will be activated (1/4 of a turn) by the parents of the patients every day. Patients will be followed-up every 2 weeks during the active phase of expansion (about 3 months) and then they will be checked every month until the completion of the study (1 year after the start of treatment). |
Intervention type | Procedure/Surgery |
Primary outcome measure | 1. Maxillary intermolar width, measured at baseline and at one-year follow-up 2. Pain, measured using a visual analogue scale (VAS) for the first 12 weeks (a total of 12 questionnaires) |
Secondary outcome measures | 1. Difficulties in speaking, measured using VAS every week for the first 12 weeks (a total of 12 questionnaires) 2. Difficulties in keeping the expander clean, measured using VAS every week for the first 12 weeks (a total of 12 questionnaires) 3. Treatment satisfaction of both the patients and the patients' parents, evaluated at one-year follow up 4. Complications, recorded during the 1-year follow up period 5. Variables either on dental casts or postero-anterior cephalograms, measured at baseline and at one-year follow up |
Overall study start date | 06/01/2016 |
Completion date | 30/11/2019 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Child |
Lower age limit | 6 Years |
Upper age limit | 14 Years |
Sex | Both |
Target number of participants | 56 (28 per centre) |
Total final enrolment | 56 |
Key inclusion criteria | 1. Children in prepubertal stage (age between 6 and 14 years) 2. Negative posterior transverse discrepancy of at least 3 mm eligible for maxillary expansion 2. The first molars should be erupted with a mixed dentition stage in early transitional period or inter-transitional period |
Key exclusion criteria | 1. Age older than 14 years or younger than 6 years 2. Deciduous dentition or mixed dentition in the late transitional period or permanent dentition 3. Maturation stage of cervical vertebrae CS3 or greater 4. Agenesis of maxillary second premolars 5. Periodontal disease 6. Neurologic or systemic disease 7. Allergy to nickel 8. Cleft lip and/or palate 9. Patients irradiated in the neck-head area 10. Chemo- or immune-therapy in the previous 5 years |
Date of first enrolment | 05/09/2016 |
Date of final enrolment | 22/11/2018 |
Locations
Countries of recruitment
- Italy
Study participating centres
50127
Italy
00133
Italy
Sponsor information
Industry
Via P. a Quaracchi, 50
Sesto Fiorentino (Firenze)
50019
Italy
Funders
Funder type
Other
No information available
Results and Publications
Intention to publish date | 01/08/2020 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | To be confirmed at a later date |
IPD sharing plan | The datasets generated during and/or analysed during the current study will be available upon request from Dr Lorenzo Franchi (lorenzo.franchi@unifi.it) |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 20/11/2020 | 23/11/2020 | Yes | No |
Results article | 11/06/2021 | 14/06/2021 | Yes | No | |
Results article | 03/01/2024 | 04/01/2024 | Yes | No |
Editorial Notes
04/01/2024: Publication reference added.
14/06/2021: Publication reference added.
23/11/2020: Publication reference and total final enrolment number added.
05/09/2019: The following changes have been made to the trial record:
1. The overall trial end date has been changed from 05/09/2018 to 30/11/2019.
2. The recruitment end date has been changed from 31/10/2019 to 22/11/2018.
3. The intention to publish date has been changed from 30/06/2020 to 01/08/2020.
18/10/2018: The following changes have been made to the trial record:
1. The target number of participants has been changed from "72" to "56 (28 per centre)"
2. The total target enrolment has been changed from "72" to "56"
3. The recruitment end date has been changed from 05/09/2018 to 31/10/2019
4. The University of Trieste has been removed as a trial participating centre and has been removed from the plain English summary
5. The intention to publish date has been changed from 05/09/2019 to 30/06/2020